Interactions of recombinant hemoglobin (rHb1.1) and endotoxin in vivo: Effects on systemic tumor necrosis factor and interleukin-6 levels in lethal and sublethal murine models of endotoxemia

Journal of Laboratory and Clinical Medicine

Volumn 130, Issue 4, 1997, Pages 427-435

  Zuckerman, Steven H ^a   Evans, Glenn F ^a   Bryan, Nancy ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031257769     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90043-3     Document Type: Article

References (41)

1. Bunn HF. The role of hemoglobin based blood substitutes in transfusion medicine. Tranfus Clin Biol 1995;2:433-9.
2. Shoemaker SA, Gerber MJ, Evans GL, Archer-Paik LE, Scoggins CH. Initial clinical experience with a rationally designed, genetically engineered recombinant human hemoglobin. Artif Cells Blood Sub Immob Biotech 1994;22:457-65.
3. Winslow RM. Blood substitutes in development. Exp Opin Invest Drugs 1996;5:1443-52.
4. Griffiths E, Cortes A, Gilbert N, Stevenson P, MacDonald S, Pepper D. Haemoglobin-based blood substitutes and sepsis. Lancet 1995;345:158-60.
5. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 1996;5:116-21.
6. Bornside GH, Bouis PJ, Cohn I. Enhancement of Escherichia coli infection and endotoxic activity by hemoglobin and ferric ammonium citrate. Surgery 1970;68:350-5.
7. White CT, Murray AJ, Smith DJ, Greene JR, Bolin RB. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 1986;108:132-7.
8. Langermans JAM, Van der Hulst MEB, Bleeker WK. Safety evaluation of a polymerized hemoglobin solution in a murine infection model. J Lab Clin Med 1996;127:428-34.
9. Pruett TL, Rotstein OD, Wells CL, Sorenson JJ, Simmons RL. Mechanism of the adjuvant effect of hemoglobin in experimental peritonitis IX: the infection-potentiating effect of hemoglobin in Escherichia coli peritonitis is strain specific. Surgery 1985;98:371-7.
10. Hoyt DB, Greenburg AG, Peskin GW, Forbes S, Reese H. Resuscitation with pyridoxalated stroma free hemoglobin: tolerance to sepsis. J Trauma 1981;21:938-42.
11. Otterbein L, Sylvester SL, Choi AMK. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 1995;13:595-601.
12. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993;122:301-8.
13. Martin W, Villani GM, Designaro J, Furchgott RF. Selective blockade of endothelium-dependent and glycerol trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-16.
14. Rioux F, Drapeau G, Marceau J. Recombinant human hemoglobin selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit aortic rings. J Cardiovasc Pharmacol 1995;25:587-94.
15. Teale DM, Atkinson AM. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992;30:839-42.
16. Cobb JP, Natanson C, Hoffman D, Lodato RF, Banks S, Koev CA, et al. N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992;176:1175-82.
17. Kaca W, Roth RI, Levin J. Hemoglobin, a newly recognized lipopolysaccharide (LPS) binding protein that enhances LPS biological activity. J Biol Chem 1994;269:25078-84.
18. Kaca W, Roth RI, Vandegriff K, Chen GC, Kuypers FA, Winslow R, et al. Effects of bacterial endotoxin on human cross-linked and native hemoglobins. Biochemistry 1995;34: 11176-85.
19. Roth RI. Hemoglobin enhances the binding of bacterial endotoxin to human endothelial cells. Thromb Haemost 1996; 76:258-62.
20. Roth RI. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994;83:2860-5.
21. Smith DJ, Winslow RM. Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med 1992;119:176-82.
22. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D. Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis fac-tor-α. Blood 1994;84:3175-81.
23. Vandegriff KD. Stability and toxicity of hemoglobin solutions. In: Blood Substitutes. Physiological basis of efficacy. Boston: Birkhauser, 1995:105-31.
24. Looker D, Mathews AJ, Neway JO, Stetler GL. Expression of recombinant human hemoglobin in Escherichia coli. Methods Enzymol 1994;231:364-74.
25. Moo-Penn WF, Wolff JA, Simon G, Vacek M, Jue DL, Johnson MH. Hemoglobin Presbyterian: b108 (G10) asparagine-lysine. A hemoglobin variant with low oxygen affinity. FEBS Lett 1978;92:53-6.
26. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992;356:258-60.
27. Siegel JH, Fabian M, Smith JA, Constantino D. Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock. J Trauma 1997;42: 199-212.
28. Zuckerman SH, Ahmari SE, Bryan-Poole N, Evans GF, Short L, Glasebrook AL. Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. Inflammation 1996;20:581-97.
29. Thomas DG, Breslow N, Gart JJ. Trend and homogeneity analyses of proportions and life table data. Comput Biomed Res 1977;10:373-81.
30. Evans GF, Zuckerman SH. Glucocorticoid-dependent and independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol 1991;21:1973-9.
31. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
32. Yoshida M, Roth RI, Levin J. The effect of cell-free hemoglobin on intravascular clearance and cellular, plasma, and organ distribution of bacterial endotoxin in rabbits. J Lab Clin Med 1995;126:151-60.
33. Roth RI, Levin FC, Levin J. Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma free hemoglobin. Infect Immun 1993;61:3209-15.
34. Conklin IL, Murray J, Ledlow A, Clark E, Hayek B, Picken H, et al. Effects of recombinant human hemoglobin on motor functions of the opossum esophagus. J Pharmacol Exp Ther 1995;273:762-7.
35. Rattan S, Rosenthal GJ, Chakder S. Human recombinant hemoglobin (rHb1.1) inhibits nonadrenergic noncholinergic (NANC) nerve-mediated relaxation of internal anal sphincter. J Pharmacol Exp Ther 1995;272:1211-6.
36. Cullen JJ, Conklin JL, Murray J, Ledlow A, Rosenthal G. Effects of recombinant human hemoglobin on opossum sphincter of Oddi motor function in vivo and in vitro. Dig Dis Sci 1996;41:289-94.
37. Lee R, Neya K, Svizzero TA, Vlahakes GJ. Limitations of the efficacy of hemoglobin based oxygen-carrying solutions. J Appl Physiol 1995;79:236-42.
38. Conover CD, Malatesta P, Lejeune L, Chang C-L, Shorr RGL. The effects of hemodilution with polyethylene glycol bovine hemoglobin (PEG-Hb) in a conscious porcine model. J Invest Med 1996;44:238-46.
39. Sharma AC, Gulati A. Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J Lab Clin Med 1994;123:299-308.
40. Schultz SC, Hamilton IN, Malcolm DS. Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 1993;35:619-25.
41. Przybelski RJ, Malcolm DS, Burris DG, Winslow RM. Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat. J Lab Clin Med 1991;117:143-51.